G01N 2333/91011
Methyltransferases
Official title: Methyltransferases (general) (2.1.1.)
G01N2333/91011 (Methyltransferases) appears on 85 US grants and 181 published applications in this corpus.
Search patents in G01N- Granted patents
- 85
- Published applications
- 181
- Assignees
- 135
- Inventors
- 421
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 2 | 1 |
| 2002 | 1 | 5 |
| 2003 | 4 | 4 |
| 2004 | 0 | 4 |
| 2005 | 1 | 4 |
| 2006 | 2 | 3 |
| 2007 | 1 | 3 |
| 2008 | 2 | 4 |
| 2009 | 2 | 9 |
| 2010 | 2 | 5 |
| 2011 | 3 | 6 |
| 2012 | 2 | 13 |
| 2013 | 5 | 8 |
| 2014 | 6 | 8 |
| 2015 | 7 | 15 |
| 2016 | 6 | 11 |
| 2017 | 8 | 15 |
| 2018 | 8 | 7 |
| 2019 | 4 | 9 |
| 2020 | 5 | 11 |
| 2021 | 0 | 5 |
| 2022 | 3 | 4 |
| 2023 | 4 | 7 |
| 2024 | 2 | 7 |
| 2025 | 2 | 7 |
| 2026 | 3 | 6 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for quantitative monitoring mRNA capping efficiency8 Sep 2026US 12,729,396 B2Thermo Finnigan LLC
- Melanogenesis detection method using FAM86A11 Aug 2026US 12,704,520 B2Research & Business Foundation Sungkyunkwan University
- KMT2A-MAML2 fusion molecules and uses thereof24 Feb 2026US 12,559,800 B2Foundation Medicine, Inc.
- Markers for the diagnosis and treatment of non-alcoholic steatohepatitis (NASH) and advanced liver fibrosis29 Jul 2025US 12,372,530 B2Beth Israel Deaconess Medical Center, Inc.
- Biomarker composition for predicting cancer malignant prognosis induced by microplastic exposure18 Feb 2025US 12,228,575 B2Korea Institute of Radiological & Medical Sciences
- Compositions and methods for detection of aberrant cdk5 expression8 Oct 2026US 2026/0309712 A1Arizona Board of Regents on Behalf of the University of Arizona
- Method for measuring methyltransferase enzyme activity1 Oct 2026US 2026/0298912 A1Honda Motor Co., Ltd.
- Novel inhibitors of histone methyltransferase nuclear localisation20 Aug 2026US 2026/0242753 A1The Council of the Queensland Institute of Medical Research
- Markers for the diagnosis and treatment of non-alcoholic steatohepatitis (nash) and advanced liver fibrosis28 May 2026US 2026/0147000 A1Beth Israel Deaconess Medical Center, Inc.
- Methods and kits for targeted cleavage and enrichment of Nucleic Acids for high-throughput analyses of user-defined genomic regions30 Apr 2026US 2026/0117293 A1
Most cited
By later US patents
- Reconstituted histone methyltransferase complex and methods of identifying modulators thereof43US 7,563,589 B2The University of North Carolina at Chapel Hill · 2009
- Inhibitors of human EZH2, and methods of use thereof41US 9,175,331 B2Epizyme, Inc. · 2015
- Inhibitors of human EZH2 and methods of use thereof38US 8,691,507 B2Epizyme, Inc. · 2014
- Inhibitors of human EZH2, and methods of use thereof36US 9,334,527 B2Epizyme, Inc. · 2016
- Inhibitors of human EZH2 and methods of use thereof35US 8,895,245 B2Epizyme, Inc. · 2014